MiR-302b improves chemotherapy efficacy in human breast cancer and affects tumor microenvironment

被引：0
|
作者：
Cataldo, A. [1 ]
Plantamura, I. [1 ]
D'Ippolito, E. [1 ]
Baroni, S. [1 ]
Palmieri, D. [2 ,3 ]
Iorio, M. V. [1 ]
机构：
[1] IRCCS Fdn Ist Nazl Tumori, Dept Expt Oncol, Start Up Unit, Milan, Italy
[2] Ohio State Univ, Coll Med, Comprehens Canc Ctr, Mol Virol Immunol & Med Genet 2Dept, Columbus, OH 43210 USA
[3] Ohio State Univ, Solid Tumor Biol Program, Columbus, OH 43210 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 61卷
关键词：
D O I：
10.1016/S0959-8049(16)61136-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
230
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] miR-302b as adjuvant therapeutic tool to improve chemotherapy efficacy in human triple-negative breast cancer
    Cataldo, Alessandra
    Plantamura, Ilaria
    D'Ippolito, Elvira
    Romero-Cordoba, Sandra
    Baroni, Sara
    Cancilia, Valeria
    Tripodo, Claudio
    Palmieri, Dario
    Iorio, Marilena V.
    [J]. CANCER RESEARCH, 2017, 77
  • [2] MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer
    Cataldo, Alessandra
    Romero-Cordoba, Sandra
    Plantamura, Ilaria
    Cosentino, Giulia
    Hidalgo-Miranda, Alfredo
    Tagliabue, Elda
    Iorio, Marilena, V
    [J]. CANCERS, 2020, 12 (08) : 1 - 20
  • [3] Downregulation of miR-302b is associated with poor prognosis and tumor progression of breast cancer
    Jing Ma
    Zhijian Zhou
    [J]. Breast Cancer, 2020, 27 : 291 - 298
  • [4] Downregulation of miR-302b is associated with poor prognosis and tumor progression of breast cancer
    Ma, Jing
    Zhou, Zhijian
    [J]. BREAST CANCER, 2020, 27 (02) : 291 - 298
  • [5] MiR-302b Suppresses Tumor Metastasis by Targeting Frizzled 6 in OSCC
    Sun, S.
    Wang, J.
    Liu, J.
    Yin, F.
    Xin, C.
    Zeng, X.
    Li, J.
    Chen, Q.
    [J]. JOURNAL OF DENTAL RESEARCH, 2021, 100 (07) : 739 - 745
  • [6] miR-302b Acts as a Tumor Suppressor in Melanoma by Targeting Smad2
    Guo, Ya'nan
    Lou, Shan
    [J]. NANOSCIENCE AND NANOTECHNOLOGY LETTERS, 2019, 11 (01) : 92 - 99
  • [7] The relationship between miR-302b and EphA2 and their clinical significance in gastric cancer
    Tang, Lanhua
    Hu, Huabin
    He, Yijing
    Mcleod, Howard L.
    Xiao, Desheng
    Chen, Pan
    Shen, Liangfang
    Zeng, Shan
    Yin, Xianli
    Ge, Jie
    Li, Li
    Ma, Jian
    Chen, Zihua
    Huang, Jin
    [J]. JOURNAL OF CANCER, 2018, 9 (17): : 3109 - 3116
  • [8] MiR-302b regulates cell functions and acts as a potential biomarker to predict recurrence in bladder cancer
    Li, Zuwei
    Zhou, Liang
    Lin, Canbin
    Pan, Xiang
    Xie, Jiansen
    Zhao, Liwen
    Quan, Jing
    Xu, Jinling
    Guan, Xin
    Xu, Weijie
    Li, Hang
    Chen, Yun
    Lai, Yongqing
    [J]. LIFE SCIENCES, 2018, 209 : 15 - 23
  • [9] LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer
    Aini, Shataer
    Bolati, Shayiti
    Ding, Wei
    Liu, Siyin
    Su, Pengcheng
    Aili, Saiding
    Naman, Yimin
    Xuekelaiti, Kuerban
    [J]. BIOENGINEERED, 2022, 13 (05) : 11430 - 11439
  • [10] Long non coding RNA NRON inhibited breast cancer development through regulating miR-302b/SRSF2 axis
    Mao, Qixin
    Li, Lianfang
    Zhang, Chongjian
    Sun, Yadong
    Liu, Shanqing
    Li, Yong
    Shen, Yan
    Liu, Zhenzhen
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (08): : 4683 - 4692
12345